Assessment of the Therapeutic Effect of Igs2.7, a Ck1Δ Protein Kinase Inhibitor, in Combination with Riluzole for the Treatment of Als-Associated Tdp-43 Proteinopathy
AuthID
P-01A-SWJ
P-01A-SWJ
© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service